Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
22:57:36 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Q:STTK - SHATTUCK LABS INC - https://www.smart-teksolutions.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
STTK - Q0.63.52·3.952.53.77+0.205.6419.41,4312,1843.54  3.855  3.544.89  0.692219:24:3208:3015 min RT 2¢

Recent Trades - Last 10 of 2184
Time ETExPriceChangeVolume
19:24:32Q3.63340.06345
18:50:09Q3.610.042
17:58:20Q3.600.03400
16:35:12Q3.800.2320
16:34:11Q3.810.2470
16:10:04Q3.770.201
16:10:04Q3.770.201
16:04:53Q3.770.201
16:04:42Q3.770.201
16:04:28Q3.770.201

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-06 08:30U:STTKNews ReleaseShattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium
2025-12-15 16:15U:STTKNews ReleaseShattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-11-20 08:00U:STTKNews ReleaseShattuck Labs to Participate in Upcoming December Investor Conferences
2025-11-06 16:30U:STTKNews ReleaseShattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights
2025-10-02 07:52U:STTKNews ReleaseShattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel
2025-08-26 06:30U:STTKNews ReleaseShattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
2025-08-21 10:17U:STTKNews ReleaseShattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease
2025-08-14 06:30U:STTKNews ReleaseShattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights
2025-08-05 06:30U:STTKNews ReleaseShattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million
2025-07-02 07:00U:STTKNews ReleaseShattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism
2025-05-01 16:20U:STTKNews ReleaseShattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights
2025-04-02 17:00U:STTKNews ReleaseShattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference
2025-03-27 07:00U:STTKNews ReleaseShattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
2025-02-20 09:00U:STTKNews ReleaseShattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
2025-02-13 16:30U:STTKNews ReleaseShattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025